Breaking News
January 6, 2009
Thomas M. Salus has been appointed vice president, contract services, Avéma Pharma Solutions, a division of PL Developments, and Richard Thome has been named senior vice president, operations of both PL Developments and Avéma Pharma Sol…
Read More »
January 6, 2009
Galapagos NV has successfully achieved a pre-clinical candidate drug in its osteoarthritis alliance with GlaxoSmithKline. Galapagos also reached milestones on other compounds in the alliance, earning milestone payments totaling $10.5 million. Under t…
Read More »
January 6, 2009
Rajiv De Silva has been appointed chief operating officer of Specialty Pharmaceuticals, Valeant Pharmaceuticals International, effective January 5, 2009. Mr. De Silva will be responsible for overseeing the U.S., Canadian and Australian specialty phar…
Read More »
